default author photo

Hiroshi Gyotoku

Nagasaki University

Katafuchi

Nagasaki

Nagasaki 850-8506

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

32

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer

Number of pages: 22 Posted: 17 Dec 2025
National Cancer Center Research Institute, Nagasaki University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Sasebo City General Hospital, affiliation not provided to SSRN, Sasebo City General Hospital, affiliation not provided to SSRN, Nagasaki University, affiliation not provided to SSRN, Nagasaki University, Sasebo City General Hospital, Nagasaki University, Nagasaki University, Nagasaki University, Sasebo City General Hospital, Nagasaki University, Sasebo City General Hospital, Sasebo City General Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagasaki University - Nagasaki University Hospital, Nagasaki University - Nagasaki University Hospital, affiliation not provided to SSRN, National Hospital Organization Ureshino Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagasaki University - Nagasaki University Hospital, Nagasaki University - Nagasaki University Hospital and Nagasaki University - Department of Respiratory Medicine
Downloads 32 (1,290,922)

Abstract:

Loading...

Limited-stage, Small Cell Lung Cancer, Amrubicin, Cisplatin, Accelerated, Hyperfractionated, radiotherapy